Medtronic Officer Files Form 144 to Sell $138.9K in Common Stock
Medtronic plc
Subscribe to track MDT
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Medtronic Officer Files Form 144 to Sell $138.9K in Common Stock
Company: Medtronic plc (MDT) Form: Form 144 | Filed: 2026/09/16 Significance: Low
Insider: Harry Skip Kiil Title: Officer | Relationship: Officer
Transaction:
• Type: Proposed Sale (Form 144)
• Shares: 1,483
• Price: ~$93.65
• Value: $138,888.59
• Owned After: N/A
Key Insight: Routine sale of 1,483 shares originating from a restricted stock vesting on July 31, 2026. The transaction represents a negligible fraction (<0.001%) of Medtronic's $119.98B market capitalization.
Comprehensive Analysis
SEC Filing Analysis: Medtronic plc (MDT)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Officer Harry Skip Kiil filed a notice of proposed sale for 1,483 common shares valued at approximately $138.9K.
- Market Impact: Neutral; transaction size is immaterial relative to Medtronic's $119.98 billion market capitalization.
Company Information
| Field | Value |
|---|---|
| Company | Medtronic plc |
| Ticker Symbol | MDT |
| CIK | 0001613103 |
| Industry | Electromedical & Electrotherapeutic Apparatus |
Insider Information
| Field | Value |
|---|---|
| Name | Harry Skip Kiil |
| CIK | 0001708062 |
| Title/Position | Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | Form 144 |
| Transaction Date | 2026/09/16 |
| Transaction Code | S (Proposed Sale) |
| Security Type | Common Stock |
| Shares Involved | 1,483 |
| Price Per Share | ~$93.65 |
| Total Value | $138,888.59 |
| Shares Owned After | N/A |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $138,888.59 |
| % of Market Cap | 0.0001% |
| Shares Transacted | 1,483 |
| % of Shares Outstanding | 0.0001% |
| Post-Transaction Ownership | N/A |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a mega-cap enterprise valued at $119.98 billion, a $138.9K sale is routine and immaterial to liquidity or price action.
- Dilution / Origin Context: The shares were originally acquired on July 31, 2026, via restricted stock vesting as part of executive equity compensation.
- Transaction Significance: Low significance given the small absolute amount and negligible fraction of total shares outstanding.
Market Impact Analysis
- Direction: Neutral
- Reasoning: Routine liquidation of vested compensation shares with no signaling value regarding operational performance.
- Expected Volume Impact: Immaterial compared to average daily trading volume.
- Sentiment Indicator: Neutral
Additional Context
- Timing: Notice filed on September 16, 2026, for execution through Fidelity Brokerage Services LLC on the NYSE.
- Special Circumstances: Filer reported no other securities sold during the past three months.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
